3 Bargain Stocks the Market Is Mispricing After the Recent Sell-Off

Nvidia is highlighted at ~22x forward P/E this year and ~17x next year as a cheap leader in AI infrastructure, with new inference chips (Groq tech, Vera Rubin) and an OpenClaw partnership targeting agentic AI. Meta trades under 21x 2026 and ~17.5x 2027 analyst estimates, with AI-driven ad growth and new monetization on WhatsApp/Threads underlining a long growth runway. Salesforce is valued at ~4x forward P/S and 15x forward P/E, projects >10% revenue CAGR through 2030, and is positioning itself for agentic AI via Data 360 and the Informatica acquisition.

Analysis

NVDA’s push from pure training into low-latency inference and agentic stacks is a structural fork: it expands addressable use cases but simultaneously compresses long-term per-inference revenue if hardware becomes more integrated with software stacks. The second-order winners are firms that control pristine, structured enterprise data and the software glue to surface it (enterprise CRMs, MDM vendors, and ad recommendation engines), since agents will pay a premium to avoid data-cleaning costs and hallucination risk — expect longer contract durations and higher gross margins for those vendors over 12–36 months.

On the supply side, the inference shift tightens short-cycle demand for high-bandwidth memory, advanced packaging and low-latency interconnects; foundry lead-times of ~6–18 months mean compute bottlenecks can persist and create reorder squeezes that benefit incumbents with fab priority. Tail risks that can reverse the trend include rapid model efficiency gains (2–3x drops in compute per inference from new architectures), a regulatory hit to targeted advertising (6–24 months), or Salesforce-like integration failures where data quality initiatives fail to scale — any of which would compress revenue multiples quickly.

The market consensus appears to underweight durable monetization engines (ads + owned data) vs. pure-play silicon growth. That creates a tidy trade taxonomy: hedgeable, cash-flow-rich exposures (Meta, Salesforce) look better-protected across macro and regulatory cycles than long-only play on compute-capex (NVDA) which is more binary to model cycles and chip-cycle reordering. Position sizing should reflect optionality: concentrated outperformance if agentic adoption accelerates, but meaningful drawdowns if models become far cheaper or ad markets soften.

Key Decisions for Investors

• Overweight CRM (buy shares, 12–24 month horizon): allocate 2–3% NAV. Thesis: data-moat re-rating as customers pay for clean master records. Target +35% upside in 12–18 months if enterprise agent pilots scale; downside -25% if execution stalls. Hedge: buy 18-month 25% OTM puts sized at 10% notional to cap black-swan downside.
• Core long META (buy shares + sell short-dated calls, 9–15 month horizon): allocate 2% NAV. Rationale: cash-flow optionality from improved ad matching; monetize through covered call to improve yield while retaining upside. Expect asymmetric 20–50% upside if ad ARPU rises; if regulatory or ad softness hits, covered calls reduce carry drag by ~2–4% annually.
• Relative-value pair — long INFA (or comparable MDM vendor) vs short NVDA delta via options, 12–18 months: go long INFA-sized 1–1 and buy long-dated NVDA calls sold to fund the position or short small NVDA notional (net neutral delta). Rationale: re-rating/m&a upside for MDM vs higher event risk and IV in NVDA. Target pair return 30%+ if consolidation occurs; risk is NVDA re-accelerates, in which case cap NVDA exposure using long calls at 6–8% of NAV.
• Tactical hedge: buy a small allocation (0.5–1% NAV) of deep OTM NVDA puts expiring 3–6 months to protect overall tech/AI exposure from a >20% drawdown tied to model-efficiency shocks or a sudden capex pause.